Literature DB >> 20589894

Timeline of cardiac dystrophy in 3-18-month-old MDX mice.

Christel Van Erp1, David Loch, Nicola Laws, Andrea Trebbin, Andrew J Hoey.   

Abstract

The dystrophin-deficient (mdx) mouse remains the most commonly used model for Duchenne muscular dystrophy (DMD). Mdx mice show a predominantly covert cardiomyopathy, the hallmark of which is fibrosis. We compared mdx and normal mice at six ages (3, 6, 9, 12, 15, and 18 months) using in vivo assessment of cardiac function, selective collagen staining, and measures of TGF-β mRNA, Evans blue dye infiltration, macrophage infiltration, and aortic wall thickness. Clear temporal progression was demonstrated, including early fragility of cardiomyocyte membranes, which has an unrelated impact on cardiac function but is associated with macrophage infiltration and fibrosis. Aortic wall thickness is less in older mdx mice. Mdx mice display impaired responses to inotropic challenge from a young age; this is indicative of altered adrenoreceptor function. We draw attention to the paradox of ongoing fibrosis in mdx hearts without a strong molecular signature (in the form of TGF-β mRNA expression).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20589894     DOI: 10.1002/mus.21716

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  26 in total

1.  AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice.

Authors:  Brian Bostick; Jin-Hong Shin; Yongping Yue; Dongsheng Duan
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

2.  rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart.

Authors:  Rui Xu; Ying Jia; Deborah A Zygmunt; Paul T Martin
Journal:  Mol Ther       Date:  2019-01-15       Impact factor: 11.454

3.  Fatty acid profile of cardiac muscle phospholipid and triacylglycerol in MDX mice and C57BL/10ScSnJ controls.

Authors:  Marc A Tuazon; Gregory C Henderson
Journal:  Lipids       Date:  2013-06-22       Impact factor: 1.880

4.  Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca2+ cycling in vivo.

Authors:  Michelle L Law; Kurt W Prins; Megan E Olander; Joseph M Metzger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-17       Impact factor: 4.733

5.  Cardiac CIP protein regulates dystrophic cardiomyopathy.

Authors:  Xin He; Jianming Liu; Fei Gu; Jinghai Chen; Yao Wei Lu; Jian Ding; Haipeng Guo; Mao Nie; Masaharu Kataoka; Zhiqiang Lin; Xiaoyun Hu; Huaqun Chen; Xinxue Liao; Yugang Dong; Wang Min; Zhong-Liang Deng; William T Pu; Zhan-Peng Huang; Da-Zhi Wang
Journal:  Mol Ther       Date:  2021-08-14       Impact factor: 11.454

Review 6.  Animal models for researching approaches to therapy of Duchenne muscular dystrophy.

Authors:  M I Zaynitdinova; A V Lavrov; S A Smirnikhina
Journal:  Transgenic Res       Date:  2021-08-18       Impact factor: 2.788

7.  Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 8.  Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies.

Authors:  Natalia Shirokova; Ernst Niggli
Journal:  J Mol Cell Cardiol       Date:  2012-12-20       Impact factor: 5.000

9.  Murine cardiosphere-derived cells are impaired by age but not by cardiac dystrophic dysfunction.

Authors:  Lien-Cheng Hsiao; Filippo Perbellini; Renata S M Gomes; Jun Jie Tan; Silvia Vieira; Giuseppe Faggian; Kieran Clarke; Carolyn A Carr
Journal:  Stem Cells Dev       Date:  2014-01-31       Impact factor: 3.272

10.  Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.

Authors:  Sarka Jelinkova; Yvonne Sleiman; Petr Fojtík; Franck Aimond; Amanda Finan; Gerald Hugon; Valerie Scheuermann; Deborah Beckerová; Olivier Cazorla; Marie Vincenti; Pascal Amedro; Sylvain Richard; Josef Jaros; Petr Dvorak; Alain Lacampagne; Gilles Carnac; Vladimir Rotrekl; Albano C Meli
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.